# Clinical Neurophysiology * **Definition:** A branch of medicine that studies the electrical activity of the nervous system to diagnose and treat neurological disorders. * **Taxonomy:** Specialties / Clinical Neurophysiology ## News * Selected news on the topic of **Clinical Neurophysiology**, for healthcare technology leaders * 4.4K news items are in the system for this topic * Posts have been filtered for tech-related keywords | Date | Title | Source | | --- | --- | --- | | 5/27/2025 | [**Clinical asset management industry report highlights major trends reshaping health care in 2025**](https://www.globenewswire.com/news-release/2025/05/27/3088776/0/en/Clinical-asset-management-industry-report-highlights-major-trends-reshaping-health-care-in-2025.html) | [[Globe Newswire]] | | 5/27/2025 | [**Clinical asset management industry report highlights major trends reshaping health care in 2025**](https://www.morningstar.com/news/globe-newswire/9458458/clinical-asset-management-industry-report-highlights-major-trends-reshaping-health-care-in-2025) | [[Morningstar]] | | 3/20/2025 | [**OURA Appoints Ricky Bloomfield, MD as Chief Medical Officer - Morningstar**](https://www.morningstar.com/news/business-wire/20250320135730/ura-appoints-ricky-bloomfield-md-as-chief-medical-officer) | [[Morningstar]] | | 3/7/2025 | [**AI and Interoperability Trends: Black Book's AMIA Membership Survey Highlights ... - Yahoo Finance**](https://finance.yahoo.com/news/ai-interoperability-trends-black-books-130000778.html) | [[Yahoo Finance]] | | 2/27/2025 | [**Philips Champions Digital Transformation at BioAsia 2025 - ICT&health International**](https://ictandhealth.com/ai-health-news/philips-champions-digital-transformation-at-bioasia-2025) | [[ICT and Health]] | | 2/25/2025 | [**5 tips to determine how tech can support your physicians - American Medical Association**](https://www.ama-assn.org/practice-management/digital/5-tips-determine-how-tech-can-support-your-physicians) | [[AMA]] | | 11/25/2024 | [**Neurology Clinical Trials Market Size Is Expected To Reach a Revenue Of USD 9,231.1 Mn By 2033, at 5.8AGR: Dimension Market Research**](https://www.globenewswire.com/news-release/2024/11/25/2986785/0/en/Neurology-Clinical-Trials-Market-Size-Is-Expected-To-Reach-a-Revenue-Of-USD-9-231-1-Mn-By-2033-at-5-8-CAGR-Dimension-Market-Research.html) | [[Globe Newswire]] | | 11/22/2024 | [**Active Pharmaceutical Ingredients (API) Global Market Overview 2024-2030: Demand for Affordable Medications and Personalized Medicine Solutions to Bolster the $345+ Billion Industry - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241122689131/en/Active-Pharmaceutical-Ingredients-API-Global-Market-Overview-2024-2030-Demand-for-Affordable-Medications-and-Personalized-Medicine-Solutions-to-Bolster-the-345-Billion-Industry---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 11/12/2024 | [**Digital health technologies play a transformative role in diabetes management and prevention**](https://www.news-medical.net/news/20241112/Digital-health-technologies-play-a-transformative-role-in-diabetes-management-and-prevention.aspx) | [[News Medical Net]] | | 11/1/2024 | [**Ferrum Health Raises $16M in Series A Funding to Unlock AI Adoption in Healthcare**](https://www.healthcareittoday.com/2024/11/01/ferrum-health-raises-16m-in-series-a-funding-to-unlock-ai-adoption-in-healthcare/) | [[Healthcare IT Today]] | | 10/29/2024 | [**Asia-Pacific Digital Diagnostics Market Analysis and Forecast, 2023-2024 & 2033: Synergetic Partnership Opportunities with Hospitals and Diagnostic Centers Fuel Opportunities - ResearchAndMarkets.com**](http://www.businesswire.com/news/home/20241029232642/en/Asia-Pacific-Digital-Diagnostics-Market-Analysis-and-Forecast-2023-2024-2033-Synergetic-Partnership-Opportunities-with-Hospitals-and-Diagnostic-Centers-Fuel-Opportunities---ResearchAndMarkets.com/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 10/22/2024 | [**Pioneering Technological Developments Propel Regenerative Medicine Forward**](https://finance.yahoo.com/news/pioneering-technological-developments-propel-regenerative-080100178.html) | [[Yahoo Finance]] | | 10/8/2024 | [**Avania Buys Spanish MedTech CRO Anagram to Enhance Its Core CRO Offering in a New European Geography**](http://www.businesswire.com/news/home/20241008530546/en/Avania-Buys-Spanish-MedTech-CRO-Anagram-to-Enhance-Its-Core-CRO-Offering-in-a-New-European-Geography/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 9/23/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2823929) | [[JAMA Network]] | | 9/20/2024 | [**Ferrum Health Secures $16M for Vendor-Neutral AI Platform**](https://hitconsultant.net/2024/09/20/ferrum-health-secures-16m-for-vendor-neutral-ai-platform/) | [[HIT Consultant]] | | 9/20/2024 | [**Artificial Intelligence - Healthcare IT News**](https://www.healthcareitnews.com/taxonomy/term/7341/m89gsv6dzcjz.jsp/page/167?page=2) | [[Healthcare IT News]] | | 9/6/2024 | [**JuneBrain Receives MDIC Advanced Manufacturing Clearing House Award; Selects Compliance Group to Implement Siemens Polarion Design Quality System**](http://www.businesswire.com/news/home/20240906392607/en/JuneBrain-Receives-MDIC-Advanced-Manufacturing-Clearing-House-Award-Selects-Compliance-Group-to-Implement-Siemens-Polarion-Design-Quality-System/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 9/2/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2823031) | [[JAMA Network]] | | 8/26/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2822727) | [[JAMA Network]] | | 8/12/2024 | [**JAMA**](https://jamanetwork.com/journals/jama/fullarticle/2822114) | [[JAMA Network]] | | 8/12/2024 | [**Audio Highlights**](https://jamanetwork.com/journals/jama/fullarticle/2822137) | [[JAMA Network]] | | 7/30/2024 | [**OM1 Contributes to Alzheimer's Disease Research With New PremiOM Dataset of Over 1 Million Patients**](http://www.businesswire.com/news/home/20240730327077/en/OM1-Contributes-to-Alzheimer%E2%80%99s-Disease-Research-With-New-PremiOM-Dataset-of-Over-1-Million-Patients/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT) | [[Business Wire]] | | 7/23/2024 | [**Mirror, Mirror: How Digital Twins Can Rescue Healthcare - Medscape**](https://www.medscape.com/viewarticle/mirror-mirror-how-digital-twins-can-rescue-healthcare-2024a1000das) | [[Medscape]] | | 6/28/2024 | [**297+ telehealth companies to know - 2024 - Becker's Hospital Review**](https://www.beckershospitalreview.com/lists/297-telehealth-companies-to-know-2024.html) | [[Beckers Hospital Review]] | | 6/25/2024 | [**Research Antibodies and Reagents Market to be Worth $6.77 Billion by 2031 - Exclusive Report by Meticulous Research®**](https://www.prnewswire.com/news-releases/research-antibodies-and-reagents-market-to-be-worth-6-77-billion-by-2031---exclusive-report-by-meticulous-research-302181579.html) | [[PR Newswire]] | ## Specialty Overview (Some LLM-derived content — please confirm with above primary sources) ### Key Players - **American Clinical Neurophysiology Society (ACNS)**: A professional organization that promotes the study and practice of clinical neurophysiology, providing guidelines and education for practitioners. - **Cumulus Neuroscience**: A company focused on home-based neurophysiology studies, particularly in Alzheimer's patients, utilizing their NeuLogiq platform for data collection. - **National Institute of Neurological Disorders and Stroke (NINDS)**: A part of the NIH, NINDS supports research and education in neurological disorders, including those related to neurophysiology. - **Neurodiagnostic Society**: An organization focused on advancing the practice of neurodiagnostics through education and certification. - **Brain.Q**: A company focused on delivering tailored therapies for central nervous system conditions, particularly in stroke rehabilitation. - **WVU Medicine Children's Neuroscience Center**: A medical institution specializing in pediatric neurology, particularly epilepsy and clinical neurophysiology. - **American Academy of Neurology (AAN)**: A professional association that provides resources and education for neurologists and neurophysiologists. - **Electroencephalography (EEG) Device Manufacturers**: Companies that produce EEG devices, which are essential for diagnosing and monitoring neurological conditions. - **HMNC Brain Health**: A clinical-stage precision psychiatry biopharma company focused on developing personalized therapies for mental health disorders. - **One Mind**: An organization that supports neuroscience and psychiatry research, providing grants and awards to early-career scientists. - **Firefly Neuroscience**: Develops AI-powered Brain Network Analytics technology to enhance drug development processes in neuroscience. - **Actio Biosciences**: A biotechnology company focused on developing innovative treatments for neurological disorders, including Charcot-Marie-Tooth disease and genetic epilepsies. - **Neurona Therapeutics**: Focuses on regenerative neural cell therapies and has appointed experts to advance its regulatory strategies. - **Biogen**: A leading biotechnology company focused on pioneering innovative science to transform patients' lives, particularly in neurology. - **Neurophet**: A company specializing in AI-based solutions for brain imaging and treatment, recently launched 'Neurophet AQUA AD,' which assesses side effects of Alzheimer's treatments. - **Brainomix**: A company providing AI-assisted tools for stroke care, enhancing decision support and treatment options. - **Synapticure**: A virtual care company focused on neurodegenerative diseases, recently raised $25 million to expand its services and partnerships. - **Altoida**: A company developing digital neurodiagnostics aimed at improving early detection and intervention for neurodegenerative disorders. ### Partnerships and Collaborations - **Research partnerships with universities**: Clinical neurophysiology departments often collaborate with academic institutions to conduct research on neurological disorders and develop new diagnostic tools. - **Research collaborations**: Academic institutions often collaborate with clinical practices to conduct research on neurophysiological disorders and treatment efficacy. - **Collaboration between hospitals and technology companies**: Many hospitals are partnering with tech companies to integrate advanced neurophysiological monitoring systems into their practices. - **Neurophet**: Collaborating with pharmaceutical firms to advance solutions for brain disease diagnosis and treatment. - **Collaboration between hospitals and technology firms**: Many hospitals partner with tech companies to integrate advanced neurophysiological monitoring systems into their practices, enhancing patient care. - **Manchester Metropolitan University**: Research project utilizing AI to create digital twin brain models for Parkinson's disease treatment. - **Cumulus Neuroscience and Alzheimer's Association**: Presented findings from the CNS-101 study at the Alzheimer's Association International Conference 2024. - **Yale University Consortium**: Collaboration to analyze large-scale neuroimaging data from stroke patients to improve healthcare quality. - **Clinical Trials**: Dr. Sunita Misra is leading global studies aimed at developing new treatments for CNS disorders, indicating partnerships with various research institutions. - **Research Collaboration**: A study on cerebellar ataxia involved clinics across Belgium, Germany, Luxembourg, and Austria, highlighting the importance of international collaboration in clinical research. - **Firefly Neuroscience with Takeda and Novartis**: Collaborated to enhance the application of their Brain Network Analytics technology in drug development. - **Synapticure**: Plans to become a CMS GUIDE provider for Alzheimer's care and advance AI-powered diagnostics. - **Altoida's Scientific Advisory Board**: Comprises experts in neuroscience and clinical neurology to enhance research and development initiatives. - **University of Plymouth and Children's Tumor Foundation**: Project to enhance understanding and treatment of meningiomas associated with NF2-related schwannomatosis. - **Zeto and Firefly Neuroscience**: This partnership aims to enhance the distribution of Zeto's FDA-cleared EEG headsets and integrate Firefly's analytics technology to improve insights into neurological conditions. - **GITEX GLOBAL's GITEX DIGI_HEALTH 5.0**: Showcased transformative health tech solutions focusing on neurology and remote patient monitoring. - **KFSHRC and Eli Lilly**: Signed a Memorandum of Understanding to enhance care for Alzheimer's patients and establish a regional hub for excellence in Alzheimer's Disease. - **Compliance Group and JuneBrain**: This collaboration focuses on implementing a digital data-centric Design Quality System to support medical device startups, enhancing patient safety and product quality. - **InvestorBrandNetwork and Octane**: Collaboration for the Medical Innovation Forum 2024, focusing on AI and innovation in healthcare. - **Holmusk and Veradigm**: Collaborating to enhance mental health research through real-world evidence and data enrichment. ### Innovations, Trends, and Initiatives - **Tele-neurophysiology**: The rise of telemedicine has led to the development of tele-neurophysiology, allowing remote monitoring and consultation for patients with neurological conditions. - **Home-based Neurophysiology Studies**: Cumulus Neuroscience's CNS-101 study demonstrated the feasibility of at-home assessments for Alzheimer's patients, showing high compliance and significant data collection. - **Focus on Pediatric Neurology**: The appointment of experts like Dr. Lawrence D. Morton and Dr. Dimitrios Arkilo emphasizes a growing focus on pediatric neurology and clinical neurophysiology. - **Wearable neurotechnology**: Emerging wearable devices that monitor brain activity and provide real-time data to clinicians for better patient management. - **AI in Neurology**: The integration of AI technologies in EEG monitoring and stroke care is enhancing diagnostic accuracy and treatment personalization, with companies like Zeto and Brainomix leading the way. - **Artificial Intelligence in neurodiagnostics**: AI algorithms are being developed to assist in the interpretation of EEG and other neurophysiological data, improving diagnostic accuracy. - **AI in Neurophysiology**: The integration of AI technologies in EEG monitoring systems, such as Zeto's AI-powered seizure detection, is enhancing diagnostic capabilities. - **Telehealth Expansion**: Synapticure's virtual platform provides access to neurologists and treatments for neurodegenerative diseases, addressing the shortage of specialists. - **AI-Driven Solutions**: Neurophet's AI-based offerings are positioning the company as a leader in medical innovation for brain diseases. - **Transcranial Direct Current Stimulation (tDCS)**: Recent studies indicate that tDCS may effectively improve motor symptoms in patients with tardive dyskinesia, showcasing innovation in non-invasive treatment methods. - **Digital NeuroMarker Platform**: Altoida's platform aims to improve early detection of Alzheimer's and other neurodegenerative disorders. - **Artificial Intelligence in EEG analysis**: AI technologies are being integrated into EEG analysis to improve accuracy and speed in diagnosing conditions such as epilepsy. - **Funding for CNS Technologies**: Clouds of Care's recent funding round reflects strong investor confidence in innovative approaches to CNS care. - **Emerging Treatments for Cerebellar Ataxia**: Research has identified a new type of cerebellar ataxia caused by specific autoantibodies, leading to potential new treatment avenues. - **AI in Drug Development**: Firefly's BNA technology aims to improve trial design and regulatory approval processes by providing objective measures of brain activity. - **One Mind Rising Star Awards**: Recognizing early-career scientists with grants and training for innovative research in neuroscience and psychiatry. ### Challenges and Concerns - **Access to care**: There are disparities in access to neurophysiological services, particularly in rural areas where specialists may be scarce. - **Rapid Progression of Neurological Disorders**: The identification of new forms of cerebellar ataxia highlights the need for timely diagnosis and intervention to prevent severe outcomes. - **Data privacy and security**: As neurophysiological data is sensitive, ensuring the privacy and security of patient information is a significant concern in the field. - **Regulatory hurdles**: Navigating the regulatory landscape for new neurophysiological devices and technologies can slow down innovation and implementation. - **Equitable Access**: The need for equitable access to advanced neurological tools and technologies, especially in underserved areas. - **Shortage of Neurologists**: The rising prevalence of neurodegenerative diseases is increasing the demand for specialized care amid a shortage of neurologists. - **Integration of technology**: Integrating new technologies into existing clinical workflows can be challenging and may require significant training and adaptation. - **Regulatory Landscapes**: Concerns regarding the evolving regulatory environment for mental health treatments, particularly with psychedelics. - **Budget Constraints**: Financial limitations hindering the deployment of AI in healthcare despite its potential benefits. - **Long COVID Treatment Options**: Need for reliable treatment options for long COVID, with current evidence showing modest effects of existing therapies. - **Clinical Trial Setbacks**: Marinus Pharmaceuticals faced significant challenges with its ganaxolone trial, raising concerns about trial design and patient enrollment impacting drug efficacy. - **Integration of new technologies**: The integration of advanced technologies into existing healthcare systems can be challenging due to compatibility issues and the need for staff training. - **Regulatory Acceptance of AI**: The FDA faces challenges in balancing innovation with safety and responsibility in the regulation of AI-driven clinical trials. - **Regulatory Hurdles**: Challenges in navigating regulatory frameworks for new digital therapeutics and AI applications in healthcare. - **Interoperability Issues**: Healthcare providers face challenges in data-sharing and standardization, impacting the integration of AI in clinical settings. - **Data Privacy and Security**: Concerns regarding the integration of AI in healthcare, particularly in maintaining patient data privacy. - **Data Privacy**: Concerns regarding the responsible use of AI and data protection in healthcare settings. - **Regulatory Compliance**: Companies like Oura are focusing on compliance with healthcare regulations while developing new health technologies. ## Related Topics [[Neurology]]; [[Child Neurology]]; [[Neurotology]]